Transcept (TSPT) Announces Common Offering
Tweet Send to a FriendGet Alerts TSPT Hot Sheet
Down)
Trade TSPT Now!
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), is offering to sell shares of its common stock in an underwritten public offering. Transcept expects to grant the underwriters a 30-day option to purchase additional shares of common stock offered in the public offering to cover over-allotments, if any. All of the shares in the offering are to be sold by Transcept. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Leerink Swann LLC and Lazard Capital Markets LLC are acting as joint book-running managers of the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Leerink Swann LLC and Lazard Capital Markets LLC are acting as joint book-running managers of the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Apricus Biosciences (APRI) Sinks on Stock Offering
- CVR Partners (UAN) Announces 12M Common Secondary Sale
- Cimatron (CIMT) Secondary Offering Priced at $6.25/Share
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
